ARBs and ACE Inhibitors for Heart Disease - myOptumHealth
Links shared publicly online about this topic.
- 87total visits
ARBs and ACE Inhibitors for Heart Disease - myOptumHealth
View full resource at myoptumhealth.com
Tags: Circulation, Heart Disease, Circulatory Disorders, Atherosclerosis, Coronary Artery Disease, Thrombotic Event, Drug
Most Recently Shared on August 8, 2011 at 3:38 pm By:
Drugs for Coronary Artery Disease: ACE Inhibitors and ARBs: ACE inhibitors and ARBs may be part of your treatmen... http://bit.ly/nRGG6t
ACE inhibitor blood-pressure drugs can have a severe side effect
philly.com — “The blood-pressure-lowering drugs known as ACE inhibitors are a mainstay of treatment for many diseases. But with growing use of these heart-helping medications, more and more patients are winding up in emergency rooms with a rare side effect that most have not been warned about: swelling around the face and neck.” View full resource at philly.com
Most Recently Shared on May 1, 2012 at 12:47 pm By:
Mary Sue McAslan PharmD, Doctor, and Pharmacist
ACE inhibitor blood-pressure drugs can have a severe side effect http://t.co/u3VAH4JE
Medical News: ESC: ACE Plus ARB Shrinks Heart and Cuts Afib - in Meeting Coverage, ESC from MedPage Today
medpagetoday.com — “PARIS -- The combination of two classes of angiotensin inhibitors markedly reduces the risk of atrial fibrillation and also reduces the size of enlarged heart chambers, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 6:56 pm By:
Tammi Jacobs Health Professional
ESC: ACE Plus ARB Shrinks Heart and Cuts Afib http://t.co/SRgf2QX
Medical News: ESC: ACE Plus ARB Shrinks Heart and Cuts Afib - in Meeting Coverage, ESC from MedPage Today
medpagetoday.com — “PARIS -- The combination of two classes of angiotensin inhibitors markedly reduces the risk of atrial fibrillation and also reduces the size of enlarged heart chambers, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 4:15 pm By:
ESC: ACE Plus ARB Shrinks Heart and Cuts Afib (CME/CE) http://t.co/ZxJm41m
Medical News: ACE Plus ARB May Risk Renal Injury - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “Renal dysfunction and hyperkalemia occurred twice as often in older patients treated with both an ACE inhibitor and an angiotensin receptor blocker (ARB) than with either agent alone, according to an” View full resource at medpagetoday.com
Most Recently Shared on March 22, 2011 at 4:28 pm By:
Luis Saldana Doctor, Emergency Physician, and Physician
Medical News: ACE Plus ARB May Risk Renal Injury - in Cardiovascular, CHF from MedPage Today http://t.co/t9pFLGB via @AddThis
Medical News: ACE Plus ARB May Risk Renal Injury - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “Renal dysfunction and hyperkalemia occurred twice as often in older patients treated with both an ACE inhibitor and an angiotensin receptor blocker (ARB) than with either agent alone, according to an” View full resource at medpagetoday.com
Most Recently Shared on March 21, 2011 at 5:36 pm By:
ACE Plus ARB May Risk Renal Injury (CME/CE): (MedPage Today) -- Renal dysfunction and… http://goo.gl/fb/gRflq
Medical News: ACE Plus ARB May Risk Renal Injury - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “Renal dysfunction and hyperkalemia occurred twice as often in older patients treated with both an ACE inhibitor and an angiotensin receptor blocker (ARB) than with either agent alone, according to an” View full resource at medpagetoday.com
Most Recently Shared on March 21, 2011 at 4:28 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday ACE Plus ARB May Risk Renal Injury (CME/CE) http://bit.ly/gWXvZO #medical #Health
ACE Inhibitors - Diabetes and ACE Inhibitors
diabetes.about.com — “Angiotensin converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. ACE inhibitors are used to treat hypertension (high blood pressure), coronary artery disease and heart failure, and to help to control the progression of diabetes and kidney disease.” View full resource at diabetes.about.com
Most Recently Shared on August 9, 2010 at 4:42 pm By:
ACE Inhibitors: Angiotensin converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. ACE... http://bit.ly/9JPgux
Does anybody have experience with... - TuDiabetes
tudiabetes.org — “Lisinopril? Generic for Prinivil , Zestril. This the medication I was put on for the abnormal Kidney function test that was part of my last blood work. The reason I ask is because it's an ACE inhibitor. Used to control heart disease including congestive heart failure. Usually combined with a diuretic. Which I'm not on. I do have heart disease but have never been put on this medication. Reading way down the list of purposes for this med is Kidney problems due to diabetes. Many of the side effects” View full resource at tudiabetes.org
Most Recently Shared on May 1, 2010 at 4:50 pm By:
Type 2 #diabetes: Does anybody have experience with...: Lisinopril? Generic for Prinivil , Zestril. This the medic... http://bit.ly/aDC6h9
Cardiology Medical News about Heart Failure
mdlinx.com — “Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and [beta]-Blockers: Subanalysis of the EPHESUS” View full resource at mdlinx.com
Most Recently Shared on January 29, 2010 at 9:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardio: Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taki http://url4.eu/1GEp4
ARBs, ACE inhibitors, and Alzheimer's
theheart.org — “Although ARBs bested ACE inhibitors in this observational cohort, the data suggest that the lowest risks for Alzheimer's disease and nursing-home admission were seen in those taking both agents.” View full resource at theheart.org
Most Recently Shared on January 28, 2010 at 2:43 pm By:
ARBs, ACE inhibitors, and Alzheimer's http://bit.ly/bTPN2D #heartwire
European Commission approves MICARDIS medication for CV protection
news-medical.net — “MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.” View full resource at news-medical.net
Most Recently Shared on November 27, 2009 at 12:40 pm By:
Stroke News: European Commission approves MICARDIS medication for CV protection: MICARDIS® is the first treatmen... http://twurl.nl/fa5ea3
Losartan dosing for heart failure
theheart.org — “UPDATED WITH COMMENTARY // The randomized trial, which compared losartan dosages of 150 mg/day and 50 mg/day,” View full resource at theheart.org
Most Recently Shared on November 17, 2009 at 1:21 pm By:
HEAAL: High-dose trumps low-dose ARB for heart failure in the ACE-inhibitor intolerant http://bit.ly/yt67D #SS09 #aha09
Adding Drug Doesn't Help Control Blood Pressure - US News and World Report
usnews.com — “No risk reduction for heart patients when ARB added to ACE inhibitor therapy, study finds” View full resource at usnews.com
Most Recently Shared on October 23, 2009 at 9:35 pm By:
Tammi Jacobs Health Professional
Adding Drug Doesn't Help Control Blood Pressure http://bit.ly/4484Ze
ACE inhibitors, ARBs, in those with preserved LV function
theheart.org — “Patients with ischemic heart disease and preserved LV function on standard therapy will gain additional benefit from taking ACE inhibitors, a new review concludes. The same cannot be said for ARBs, a drug class for which the evidence is much weaker, but these are a good substitute in those who cannot tolerate ACE inhibitors, the authors say.” View full resource at theheart.org
Most Recently Shared on October 20, 2009 at 1:14 pm By:
heartwire: ACE inhibitors of benefit in ischemic heart disease patients with preserved LV function http://bit.ly/2Avfpq
FDA approves Boehringer Ingelheim's MICARDIS for the reduction of risk of heart attack
news-medical.net — “Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved a new indication for MICARDIS® (telmisartan) for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors. MICARDIS® is the first treatment in its class to be approved for this indication.” View full resource at news-medical.net
Most Recently Shared on October 19, 2009 at 5:06 pm By:
Stroke News: FDA approves Boehringer Ingelheim's MICARDIS for the reduction of risk of heart attack:.. http://twurl.nl/n1anwp
Advertisement
